# PDA Treatment With Ibuprofen and Changes in Tissue Oxygenation.

> **NCT05325177** · PHASE4 · UNKNOWN · sponsor: **Ottawa Hospital Research Institute** · enrollment: 30 (estimated)

## Conditions studied

- Patent Ductus Arteriosus After Premature Birth

## Interventions

- **DRUG:** Standard Dose Ibuprofen
- **DRUG:** High Dose Ibuprofen

## Key facts

- **NCT ID:** NCT05325177
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-01
- **Primary completion:** 2024-12-01
- **Final completion:** 2024-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05325177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05325177, "PDA Treatment With Ibuprofen and Changes in Tissue Oxygenation.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05325177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*